False Equivalence of Four-month and Six-month ATT Regimen: A Case of Comparing Apples and Oranges

In this regard, the trial by Velayutham et al. is commendable.

Nevertheless, it has certain limitations. While authors claim that the regimen has a high cure rate and acceptable recurrence rate, we have two main concerns regarding the applicability of this trial.